PD-0299685
PD-0299685 is a gabapentinoid which was under development for the treatment of insomnia and vasomotor symptoms related to menopause as well as interstitial cystitis. It is taken orally. PD-0299685 was under development by Pfizer. It reached Phases of [clinical research#Phase II|phase 2] clinical trials prior to the discontinuation of its development.